Presumed risk factors and biomarkers for severe respiratory syncytial virus disease and related sequelae: Protocol for an observational multicenter, case-control study from the Respiratory Syncytial Virus Consortium in Europe (RESCEU)

Presumed risk factors and biomarkers for severe respiratory syncytial virus disease and related sequelae: Protocol for an observational multicenter, case-control study from the Respiratory Syncytial Virus Consortium in Europe (RESCEU)

Respiratory syncytial virus (RSV) is the leading viral pathogen associated with acute lower respiratory tract infection and hospitalization in children < 5 years of age worldwide. While there are known clinical risk factors for severe RSV infection, the majority of those hospitalized are previous...

Descripció completa

Dades bibliogràfiques
Autors principals:	Jefferies, K, Drysdale, SB, Robinson, H, Clutterbuck, EA, Blackwell, L, McGinley, J, Lin, G-L, Galal, U, Nair, H, Aerssens, J, Öner, D, Langedijk, A, Bont, L, Wildenbeest, JG, Martinon-Torres, F, Rodríguez-Tenreiro Sánchez, C, Nadel, S, Openshaw, P, Thwaites, R, Widjojoatmodjo, M, Zhang, L, Nguyen, TL-A, Giaquinto, C, Giordano, G, Baraldi, E, Pollard, AJ
Altres autors:	Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2020

Ítems similars

Respiratory Syncytial Virus Consortium in Europe (RESCEU) birth cohort study: defining the burden of infant respiratory syncytial virus disease in Europe
per: Wildenbeest, JG, et al.
Publicat: (2020)

Clinical and viral factors associated with disease severity and subsequent wheezing in infants with respiratory syncytial virus infection
per: McGinley, JP, et al.
Publicat: (2022)

Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study
per: Korsten, K, et al.
Publicat: (2021)

A systematic review and meta-analysis of animal studies investigating the relationship between serum antibody, T lymphocytes, and respiratory syncytial virus disease
per: McGinley, J, et al.
Publicat: (2021)

A genome-wide association study of respiratory syncytial virus infection severity in infants
per: Johnson, M, et al.
Publicat: (2024)

Transcriptomic analysis of biomarkers of respiratory syncytial virus disease
per: McGinley, J
Publicat: (2020)

Single-cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants
per: Zivanovic, N, et al.
Publicat: (2023)

Simultaneous viral whole-genome sequencing and differential expression profiling in respiratory syncytial virus infection of infants
per: Lin, G-L, et al.
Publicat: (2020)

Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants
per: Nevena Zivanovic, et al.
Publicat: (2023-12-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
per: Andrea Gastaldi, et al.
Publicat: (2021-12-01)

Respiratory syncytial virus: Immunisation and prophylaxis
per: Barr, R, et al.
Publicat: (2018)

Systemic signature of the lung response to respiratory syncytial virus infection.
per: Jeroen L A Pennings, et al.
Publicat: (2011-01-01)

Vaccination against respiratory syncytial virus
per: Green, CA, et al.
Publicat: (2020)

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
per: Lin, G-L, et al.
Publicat: (2021)

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
per: Salaun, B, et al.
Publicat: (2023)

An overview of respiratory syncytial virus.
per: Jia Meng, et al.
Publicat: (2014-04-01)

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials
per: Billard, MN, et al.
Publicat: (2022)

Respiratory syncytial virus: diagnosis, prevention and management
per: Barr, R, et al.
Publicat: (2019)

Mucosal Immune Responses to Respiratory Syncytial Virus
per: Megan V. C. Barnes, et al.
Publicat: (2022-03-01)

Seasonal immunisation against respiratory syncytial virus disease
per: Koos Korsten, et al.
Publicat: (2017-08-01)

Respiratory syncytial virus: diagnosis, prevention and management
per: Rachael Barr, et al.
Publicat: (2019-07-01)

Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
per: Lin, G-L, et al.
Publicat: (2024)

Seasonality of respiratory syncytial virus infection.
per: Waris, M, et al.
Publicat: (2006)

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
per: Gu-Lung Lin, et al.
Publicat: (2021-08-01)

Bacteremia in Children Hospitalized with Respiratory Syncytial Virus Infection.
per: Miriam Cebey-López, et al.
Publicat: (2016-01-01)

The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
per: Wildenbeest, JG, et al.
Publicat: (2022)

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
per: Bruno Salaun, et al.
Publicat: (2023-10-01)

Landscape of respiratory syncytial virus
per: Yuping Duan, et al.
Publicat: (2024-12-01)

An update on respiratory syncytial virus
per: Antonio Piralla, et al.
Publicat: (2023-10-01)

Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe
per: Öner, D, et al.
Publicat: (2024)

Prevalence of human respiratory syncytial virus circulating in Iran
per: Vahid Salimi, et al.
Publicat: (2016-03-01)

Biomarkers for disease severity in children infected with respiratory syncytial virus: a systematic literature review
per: Öner, D, et al.
Publicat: (2020)

Potential therapeutic implications of new insights into respiratory syncytial virus disease
per: Openshaw Peter JM
Publicat: (2002-06-01)

Antibody-mediated protection against respiratory syncytial virus in children
per: Emma L. Coindy, et al.
Publicat: (2024-10-01)

Immunological and inflammatory biomarkers of susceptibility and severity in adult respiratory syncytial virus infections
per: Wiseman, DJ, et al.
Publicat: (2020)

Immunoprophylaxis of Respiratory Syncytial Virus Infection in Children
per: A. A. Baranov, et al.
Publicat: (2015-12-01)

Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
per: Gu-Lung Lin, et al.
Publicat: (2021-10-01)

The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus
per: Annefleur C. Langedijk, et al.
Publicat: (2024-04-01)

Respiratory syncytial virus epidemiology in Turkey
per: Güler Kanra, et al.
Publicat: (2005-10-01)

Severe respiratory syncytial virus disease
per: Yolanda Peña-López, et al.
Publicat: (2024-10-01)